KBIO
Turing Pharmaceuticals Inc's controversial CEO Martin Shkreli bought 1.2 million shares of the company that is about to wind down its operations.
The shares were bought at prices ranging between 61 cents and $2.43 each on Monday and Tuesday, a regulatory filing showed on Wednesday.
Shkreli now owns 1.6 million shares, making him Kalobios' largest shareholder with a 39 percent stake
On Friday, KaloBios said it would wind down its operations and liquidate assets.
Va a ser que sí es corto. Voy a intentarlo.
Gap cerrado en 16,25- Tiene otro gap en 36,95
Edito: restricción de cortos hasta hoy a las 2. En pre se podrá meter ya mañana.
Análisis de liquidación aquí de hace 3 días:
http://www.goodetrades.com/2015/11/a-short-analysis-of-kalobios-pharmaceuticals-kbio-liquidation-value/?utm_source=twitterfeed&utm_medium=twitter
«Después de nada, o después de todo/ supe que todo no era más que nada.»